Cover Image
市場調查報告書

LegoChem Biosciences, Inc : 產品平台分析

LegoChem Biosciences, Inc - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 306086
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
LegoChem Biosciences, Inc : 產品平台分析 LegoChem Biosciences, Inc - Product Pipeline Review - 2016
出版日期: 2016年05月25日 內容資訊: 英文 37 Pages
簡介

LegoChem Biosciences, Inc 是在韓國設置據點的製藥公司,致力於小分子藥的研究開發。該公司同時也提供共同/委託研究,化學程式庫套組,客製化的化合物合成,篩檢服務等各種服務。

本報告提供LegoChem Biosciences, Inc 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,後期階段及中止的計劃等相關資訊。

LegoChem Biosciences, Inc的基本資料

  • LegoChem Biosciences, Inc概要
  • 主要資訊
  • 企業資料

LegoChem Biosciences, Inc:R&D概要

  • 主要的治療範圍

LegoChem Biosciences, Inc:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

LegoChem Biosciences, Inc:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

LegoChem Biosciences, Inc:藥物簡介

LegoChem Biosciences, Inc:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

LegoChem Biosciences, Inc:暫停中的計劃

LegoChem Biosciences, Inc:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08050CDB

Summary

Global Markets Direct's, 'LegoChem Biosciences, Inc - Product Pipeline Review - 2016', provides an overview of the LegoChem Biosciences, Inc's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by LegoChem Biosciences, Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of LegoChem Biosciences, Inc
  • The report provides overview of LegoChem Biosciences, Inc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses LegoChem Biosciences, Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features LegoChem Biosciences, Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate LegoChem Biosciences, Inc's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for LegoChem Biosciences, Inc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding LegoChem Biosciences, Inc's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • LegoChem Biosciences, Inc Snapshot
    • LegoChem Biosciences, Inc Overview
    • Key Information
    • Key Facts
  • LegoChem Biosciences, Inc - Research and Development Overview
  • Key Therapeutic Areas
  • LegoChem Biosciences, Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • LegoChem Biosciences, Inc - Pipeline Products Glance
    • LegoChem Biosciences, Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • LegoChem Biosciences, Inc - Drug Profiles
    • LCB-010699
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LCB-030110
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LCB-100200
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LCB-140110
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LCB-1414XX
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LCB-141XXX
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibody Conjugate for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Protein 1 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Protein 2 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Protein for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Anaplastic Lymphoma Kinase for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Blood Factor XIa for CAHD and Stroke
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Hypoxia inducible factor-1 for Ophthalmology
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • LegoChem Biosciences, Inc - Pipeline Analysis
  • LegoChem Biosciences, Inc - Pipeline Products by Target
  • LegoChem Biosciences, Inc - Pipeline Products by Route of Administration
  • LegoChem Biosciences, Inc - Pipeline Products by Molecule Type
  • LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action
  • LegoChem Biosciences, Inc - Dormant Projects
  • LegoChem Biosciences, Inc - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • LegoChem Biosciences, Inc, Key Information
  • LegoChem Biosciences, Inc, Key Facts
  • LegoChem Biosciences, Inc - Pipeline by Indication, 2016
  • LegoChem Biosciences, Inc - Pipeline by Stage of Development, 2016
  • LegoChem Biosciences, Inc - Monotherapy Products in Pipeline, 2016
  • LegoChem Biosciences, Inc - Partnered Products in Pipeline, 2016
  • LegoChem Biosciences, Inc - Partnered Products/ Combination Treatment Modalities, 2016
  • LegoChem Biosciences, Inc - Out-Licensed Products in Pipeline, 2016
  • LegoChem Biosciences, Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • LegoChem Biosciences, Inc - Preclinical, 2016
  • LegoChem Biosciences, Inc - Discovery, 2016
  • LegoChem Biosciences, Inc - Pipeline by Target, 2016
  • LegoChem Biosciences, Inc - Pipeline by Route of Administration, 2016
  • LegoChem Biosciences, Inc - Pipeline by Molecule Type, 2016
  • LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action, 2016
  • LegoChem Biosciences, Inc - Dormant Developmental Projects,2016

List of Figures

  • LegoChem Biosciences, Inc - Pipeline by Top 10 Indication, 2016
  • LegoChem Biosciences, Inc - Pipeline by Stage of Development, 2016
  • LegoChem Biosciences, Inc - Monotherapy Products in Pipeline, 2016
  • LegoChem Biosciences, Inc - Out-Licensed Products in Pipeline, 2016
  • LegoChem Biosciences, Inc - Pipeline by Target, 2016
  • LegoChem Biosciences, Inc - Pipeline by Route of Administration, 2016
  • LegoChem Biosciences, Inc - Pipeline by Molecule Type, 2016
  • LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action, 2016
Back to Top